Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Weight-Related Comorbidity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06277934
What this trial is testing

RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
Obesity
Regor Pharmaceuticals Inc. 73
Not applicableLooking for participantsNCT06890169
What this trial is testing

OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities

Who this might be right for
Obesity and Type 2 DiabetesNAFLD - Non-Alcoholic Fatty Liver DiseaseHypertension+2 more
Changi General Hospital 120
Large-scale testing (Phase 3)Active Not RecruitingNCT06972459
What this trial is testing

Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

Who this might be right for
ObesityOverweight
Eli Lilly and Company 800
Testing effectiveness (Phase 2)Active Not RecruitingNCT06965413
What this trial is testing

Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity

Who this might be right for
ObesityOverweightOverweight With One Weight Related Comorbidity
Hoffmann-La Roche 285
Large-scale testing (Phase 3)Looking for participantsNCT06439277
What this trial is testing

Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

Who this might be right for
ObesityWeight Gain
Eli Lilly and Company 300
Not applicableStudy completedNCT05795166
What this trial is testing

Understand the Distribution of Obesity Classes and Obesity Related Diseases in People With Obesity Across Countries in Czech Republic, Hungary and Poland

Who this might be right for
Obesity
Novo Nordisk A/S 1,241
Early research (Phase 1)Study completedNCT06023095
What this trial is testing

LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities

Who this might be right for
OverweightObesity
Eli Lilly and Company 24
Large-scale testing (Phase 3)Looking for participantsNCT07481747
What this trial is testing

Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)

Who this might be right for
ObesityOverweight (Without Type 2 Diabetes) With Weight-related Comorbidities
Hudson Biotech 2,539
Testing effectiveness (Phase 2)Study completedNCT04881760
What this trial is testing

LY3437943 in Participants Who Have Obesity or Are Overweight

Who this might be right for
ObesityOverweight
Eli Lilly and Company 338
Large-scale testing (Phase 3)Looking for participantsNCT07784725
What this trial is testing

Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Who this might be right for
Obesity or Overweight
AstraZeneca 2,500
Testing effectiveness (Phase 2)Study completedNCT07081958
What this trial is testing

A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

Who this might be right for
Obesity or Overweight
Hoffmann-La Roche 352
Not applicableEnded earlyNCT00487162
What this trial is testing

The Association Between Peri-Operative Hyperglycemia and Major Morbidity and Mortality

Who this might be right for
Hyperglycemia
University of Medicine and Dentistry of New Jersey 56
Large-scale testing (Phase 3)Study completedNCT06047548
What this trial is testing

LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
OverweightObesity
Eli Lilly and Company 441
Large-scale testing (Phase 3)Not Yet RecruitingNCT07790861
What this trial is testing

Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems

Who this might be right for
ObesityOverweight
Eli Lilly and Company 192
Testing effectiveness (Phase 2)Study completedNCT06703021
What this trial is testing

A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Who this might be right for
ObesityOverweightChronic Weight Management
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics 85
Large-scale testing (Phase 3)Looking for participantsNCT07279194
What this trial is testing

Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes

Who this might be right for
Obesity & Overweight
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 825
Large-scale testing (Phase 3)Study completedNCT04660643
What this trial is testing

Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss

Who this might be right for
ObesityOverweight
Eli Lilly and Company 783
Testing effectiveness (Phase 2)Study completedNCT07281937
What this trial is testing

Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
ObesityOverweight
Verdiva Bio Dev Limited 206
Not applicableStudy completedNCT05623163
What this trial is testing

Evaluation of Health Improvement in Obese Patients With Obesity-related Comorbidities Followed by EndoZip Procedure

Who this might be right for
Obesity
Nitinotes Surgical Ltd. 38
Not applicableNot Yet RecruitingNCT07609160
What this trial is testing

Effectiveness of Combined GLP-1/GIP Dual Agonist Therapy and Structured Exercise on Skeletal Muscle Morphology, Quality, and Physical Function in Overweight and Obese Individuals

Who this might be right for
ObesitySarcopeniaOverweight (Without Type 2 Diabetes) With Weight-related Comorbidities
Acibadem University 108
Next Page